
Procter & Gamble rose 15.7% from $145.50 to a 1-year high of $168.32, ahead of the S&P 500's +10.5%. Its worst day was Dec 8 (−3.6%), and its low came Jan 7 at $138.04.
Story events cover the past 12 months · Times ET
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Procter & Gamble shares fell 3.6%, while the S&P 500 fell 0.3%.
−3.6%, the year's worst day · S&P 500 −0.3%
Procter & Gamble closed at its lowest level of the year, 5.1% below where the year started.
−1.3% · S&P 500 −0.3%
EPS of $1.88 beat the $1.86 estimate on $22.2B revenue (est. $22.3B); FY revenue guidance of $85.1B–$88.5B against the $86.7B consensus.
+1.9% · S&P 500 +0.5%
EPS of $1.59 beat the $1.56 estimate on $21.2B revenue (est. $20.5B); FY revenue guidance of $85.1B–$88.5B against the $86.6B consensus.
+2.5% · S&P 500 +0.8%
Procter & Gamble shares rose 4.1%, while the S&P 500 fell 2.6%.
+4.1% · S&P 500 −2.6%
EPS of $1.43 beat the $1.42 estimate on $21.2B revenue (est. $21.4B); FY revenue guidance of $85.1B–$86.8B against the $89.5B consensus.
−1.9% · S&P 500 −1.5%
EPS of $2.00 beat the $1.89 estimate on $23.3B revenue (est. $22.8B); FY revenue guidance of $86.0B–$87.7B against the $88.8B consensus.
+4.9%, the year's best day · S&P 500 −1.2%
Where it ended: a 1-year high close of $168.32 on Nov 9, 2026. Up next: Q2 2027 earnings on Jan 21, 2027 (EPS est. $1.81, revenue est. $22.8B).